In implementing the Inflation Reduction Act (IRA), Centers for Medicare & Medicaid Services (CMS) has an obligation to ensure that plans, manufacturers and pharmacy benefit managers do not improperly shift their burdens to beneficiaries. Read Medicare Right’s article on the effects of the Prescription Drug Law.

The Inflation Reduction Act (IRA) has a rolling timeline, with changes starting in 2023 and continuing for many years, including specific dates for benefits like the $35 cap on insulin for Medicare recipients in 2023 and the cap on out-of-pocket prescription drug costs at $2,000 for Medicare in 2025, $2,100 in 2026…